SIGNIFICANCE OF RS2368564 AND RS41317140 RENIN GENE POLYMORPHISMS FOR CORONARY ARTERY IN-STENT RESTENOSIS DEVELOPMENT Article Bogatyreva K., Azova M., Shugushev Z., Blagonravov M., Aghajanyan A., Tskhovrebova L., Aissa A.A., Gigani O. FEBS Open Bio. FEBS Press. Vol. 11. 2021. P. 247-247
GENE POLYMORPHISMS OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM AS RISK FACTORS FOR THE DEVELOPMENT OF IN-STENT RESTENOSIS IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE Article Azova M., Timizheva K., Aissa A.A., Blagonravov M., Gigani O., Aghajanyan A., Tskhovrebova L. Biomolecules. MDPI AG. Vol. 11. 2021.
GENOME DAMAGE IN CHILDREN WITH CLASSICAL EHLERS-DANLOS SYNDROME - AN IN VIVO AND IN VITRO STUDY Article Aghajanyan A., Fucic A., Tskhovrebova L., Gigani O., Konjevoda P. European Journal of Medical Genetics. Elsevier Masson SAS. 2018.
(-75)G ALLELE OF APOA1 GENE IS ASSOCIATED WITH NON-ATTAINMENT OF TARGET LIPID LEVELS IN VERY HIGH CARDIOVASCULAR RISK PATIENTS Article Vorobyeva M., Gigani O., Azova M., Villevalde S., Kobalava Z. European Journal of Heart Failure. Elsevier Science Publishing Company, Inc.. Vol. Vol19. 2017. P. 159-159
MONOCYTE CHEMOATTRACTANT PROTEIN-1 LEVEL AND (-75)G/A POLYMORPHISM OF APOA1 GENE PREDICT RESPONSE AND RESISTANCE TO INTENSIVE STATIN THERAPY IN VERY HIGH CARDIOVASCULAR RISK PATIENTS Article Kobalava Z., Vorobyeva M., Gigani O., Villevalde S., Azova M. European Heart Journal. Vol. 38. 2017. P. 1252-1252
MONOCYTE CHEMOATTRACTANT PROTEIN-1 LEVEL AND (-75)G/A POLYMORPHISM OF APOA1 GENE PREDICT RESPONSE AND RESISTANCE TO INTENSIVE STATIN THERAPY IN VERY HIGH CARDIOVASCULAR RISK PATIENTS Article Vorobyeva M., Gigani O., Villevalde S., Azova M., Kobalava Z. European Heart Journal. Vol. Vol38. 2017.